Serum thyroxine levels in schizophrenic and affective disorder diagnostic subgroups

Area of Science:

• Endocrinology
• Psychiatry
• Neuroscience

Background:

• Thyroid hormone levels are crucial for brain function.
• Previous research has explored the link between thyroid hormones and psychiatric disorders, but longitudinal changes during recovery are less understood.

Purpose of the Study:

• To investigate changes in serum free thyroxine (FT4) and total thyroxine (TT4) levels during hospitalization and clinical recovery across four psychiatric diagnostic groups.
• To explore the potential of FT4 levels for differential diagnosis between bipolar I disorder, manic, and paranoid schizophrenia.

Main Methods:

• Serum FT4 and TT4 levels were measured bi-weekly in 29 male inpatients across four groups: paranoid schizophrenia (PS), undifferentiated schizophrenia, bipolar I disorder (manic), and major depressive disorder.
• Changes in thyroxine levels from admission to discharge (delta values) were analyzed and compared between groups.

Main Results:

• The paranoid schizophrenia group showed a significant mean rise in both TT4 and FT4 during clinical recovery, unlike the other three groups which exhibited mean decreases.
• 75% of PS patients had increased TT4 during recovery versus 4% in other groups; 50% of PS patients had increased FT4 versus 14% in other groups.
• A significant difference in FT4 levels at admission was observed between bipolar I (manic) and PS patients.

Conclusions:

• Thyroxine level dynamics during recovery differ significantly between paranoid schizophrenia and other major psychiatric disorders.
• Longitudinal assessment of thyroxine levels alongside symptom changes is important for understanding psychiatric disorders.
• FT4 levels at admission may aid in differentiating bipolar I disorder (manic) from paranoid schizophrenia.